SCHEMBL9927799

SCHEMBL9927799

CC1CC(C)(C)c2ccc(C(=O)C(C)(C)O)cc21

nearest known ligand 0.38

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
RXRA P19793 13/20 0.38
RXRB P28702 9/20 0.38
RXRG P48443 6/20 0.33
RARB P10826 6/20 0.33
RARG P13631 6/20 0.33
CYP26A1 O43174 4/20 0.32
CYP26B1 Q9NR63 3/20 0.32
RARA P10276 4/20 0.31
PTGS1 P23219 1/20 0.31
PTGS2 P35354 1/20 0.31
CYP3A4 P08684 2/20 0.31
CRABP2 P29373 1/20 0.31
NTRK1 P04629 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23957703 1.00 RXRA (0.38) RXRARXRBRXRGRARBRARG
SCHEMBL9906973 0.90 RXRA (0.39) RXRARXRBRXRGRARBRARG
SCHEMBL23033699 0.89 RXRA (0.35) RXRARXRBRXRGRARBRARG
SCHEMBL1071564 0.82 RXRA (0.46) RXRARXRBRXRGRARBRARG
SCHEMBL17530495 0.82 MAPT (0.42) RXRARXRBRXRGRARBRARG
SCHEMBL14433230 0.79 POLB (0.36) RXRARXRB
SCHEMBL13533488 0.77 RXRA (0.33) RXRARXRB
SCHEMBL24140842 0.72
SCHEMBL6276772 0.72 OPRM1 (0.39)
SCHEMBL29005329 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 90 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3911687-B1 LIMONENE-BASED (METH)ACRYLATES FOR USE IN 3D PRINTING BASF SE (DE) 2023-11-01 EP disclosed
US-11731903-B2 Water-blocking systems including fibers coated with liquid radiation curable SAP compositions COVESTRO (NETHERLANDS) B.V. (NL) 2023-08-22 US disclosed
US-11731903-B2 Water-blocking systems including fibers coated with liquid radiation curable SAP compositions COVESTRO (NETHERLANDS) B.V. (NL) 2023-08-22 US disclosed
US-20230241675-A1 COMPOSITIONS, COMPRISING PLATELET-SHAPED TRANSITION METAL PARTICLES BASF SE (DE) 2023-08-03 US disclosed
WO-2023072740-A1 A METHOD FOR PRODUCING INTERFERENCE ELEMENTS BASF SE (DE) 2023-05-04 WO disclosed
US-20230002631-A1 WATER-WASHABLE COMPOSITIONS FOR USE IN 3D PRINTING BASF SE (DE) 2023-01-05 US disclosed
EP-3914458-B1 SECURITY ELEMENT BASF SE (DE) 2022-12-21 EP disclosed
US-20220220028-A1 WATER-BLOCKING SYSTEMS INCLUDING FIBERS COATED WITH LIQUID RADIATION CURABLE SAP COMPOSITIONS COVESTRO NETHERLANDS BV (NL) 2022-07-14 US disclosed
US-20220220284-A1 COMPOSITIONS, COMPRISING SILVER NANOPLATELETS BASF SE (DE) 2022-07-14 US disclosed
US-11319246-B2 Water-blocking systems including fibers coated with liquid radiation curable SAP compositions COVESTRO (NETHERLANDS) B.V. (NL) 2022-05-03 US disclosed
US-20100090455-A1 APPARATUS AND METHOD FOR MANUFACTURING A SECURITY PRODUCT CIBA CORPORATION (US) 2010-04-15 US disclosed
US-20100021831-A1 TRANSPARENT COLOURANTS AND COLOURANT COMPOSITIONS, AND THEIR USE CIBA CORPORATION (US) 2010-01-28 US disclosed
US-20090293769-A1 BLUE PHTHALOCYANINE PIGMENT COMPOSITION AND ITS PREPARATION CIBA CORPORATION (US) 2009-12-03 US disclosed
WO-2009062867-A1 A METHOD FOR PRODUCING AN OPTICALLY VARIABLE IMAGE CARRYING SHIM BASF SE (CH) 2009-05-22 WO disclosed
US-20080206658-A1 Compositions Containing Anthraquinone Dyes HUNTSMAN INTERNATIONAL LLC (US) 2008-08-28 US disclosed
WO-2008061930-A1 APPARATUS AND METHOD FOR MANUFACTURING A SECURITY PRODUCT CIBA HOLDING INC. (CH) 2008-05-29 WO disclosed
US-20080095950-A1 Compositions Containing Phthalocyanine Dyes HUNTSMAN INTERNATIONAL LLC (US) 2008-04-24 US disclosed
US-20080010756-A1 Cyanopyridine-Based Azo Dyes HUNTSMAN INTERNATIONAL LLC (US) 2008-01-17 US disclosed
WO-2007060125-A1 REACTIVE SILICON OXIDE FLAKES CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2007-05-31 WO disclosed
EP-1772479-A1 Silicon coated release substrate Ciba Specialty Chemicals Holding Inc. (CH) 2007-04-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100021831-A1 TRANSPARENT COLOURANTS AND COLOURANT COMPOSITIONS, AND THEIR USE NDUFA10, STARD10, RPS10 RXRA 559/4885RXRB 606/4885RXRG 474/4885
US-20080095950-A1 Compositions Containing Phthalocyanine Dyes ZKSCAN2, INCENP, CRY2 RXRA 1108/4885RXRB 845/4885RXRG 1525/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.